Literature DB >> 5091532

Combined live measles, mumps, rubella vaccine. Immunological response.

S Krugman, G Muriel, V J Fontana.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5091532     DOI: 10.1001/archpedi.1971.02100160050003

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


× No keyword cloud information.
  7 in total

1.  Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.

Authors:  T A Swartz; W Klingberg; M A Klingberg
Journal:  Infection       Date:  1974       Impact factor: 3.553

Review 2.  Immunization today--a review.

Authors:  M I Marks; M Brazeau; R M Shapera
Journal:  Can Med Assoc J       Date:  1973-06-02       Impact factor: 8.262

3.  Recent developments in immunization.

Authors:  F B Hodges
Journal:  Calif Med       Date:  1972-08

Review 4.  Measles Vaccine.

Authors:  Diane E Griffin
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

5.  Benefits, risks and costs of immunization for measles, mumps and rubella.

Authors:  C C White; J P Koplan; W A Orenstein
Journal:  Am J Public Health       Date:  1985-07       Impact factor: 9.308

6.  Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination.

Authors:  Carey Farquhar; Dalton Wamalwa; Sara Selig; Grace John-Stewart; Jennifer Mabuka; Maxwel Majiwa; William Sutton; Nancy Haigwood; Grace Wariua; Barbara Lohman-Payne
Journal:  Pediatr Infect Dis J       Date:  2009-04       Impact factor: 2.129

Review 7.  Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production.

Authors:  Kostlend Mara; Meiling Dai; Aaron M Brice; Marina R Alexander; Leon Tribolet; Daniel S Layton; Andrew G D Bean
Journal:  Vaccines (Basel)       Date:  2021-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.